Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs (CIMT)

AstraZeneca

Status: Completed

Conditions: Cardiovascular Disease

Treatments: Biological: Blood sample testing for hs-CRP; Procedure: Measurement of the Carotid Intima Media thickness

Study type: Interventional

Funder types: Industry

Identifiers

NCT00970918

D3560L00092

Details and patient eligibility

About

The purpose of this study is to obtain the distribution of measurements of the intima media thickness of carotid arteries in people with high cardiovascular risk.

Enrollment: 2,609 patients

Sex: All

Ages: 30 to 69 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provision of signed informed consent.
• Patients with at least two CVD risk factors but not on lipid-lowering agents

Exclusion criteria

• Subjects with CHD, any conditions that may affect hs-CRP levels.
• Subjects on any lipid-lowering drug treatment within the last 3 months prior study entry.

Trial design

2,609 participants in 1 patient group

1

Experimental group

Treatment:

Biological: Blood sample testing for hs-CRP

Procedure: Measurement of the Carotid Intima Media thickness